NovaCell Technology Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $9.1M

  • Investors
  • 4

NovaCell Technology General Information

Description

Developer of biomaterials and pharmaceuticals intended to balance the immune system healthily. The company provides contract research services for new drug development as well as conducting collaborative research products with various other domestic and foreign universities, research labs, and institutions, enabling patients to cure diseases, such as atopy, asthma, dry eye disease, and inflammatory bowel disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Corporate Office
  • 77, Cheongam-ro, Nam-gu
  • Pohang University of Science and Technology
  • Pohang-si, Gyeongsangbuk-do
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NovaCell Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC $9.1M 000.00 Completed Generating Revenue
1. Seed Round 28-Sep-2020 00.000 00.000 Completed Generating Revenue
To view NovaCell Technology’s complete valuation and funding history, request access »

NovaCell Technology Patents

NovaCell Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4173632-A1 Pharmaceutical composition or health functional food for prevention and treatment of obesity containing powder of novel hybrid mushroom as active ingredient Pending 29-Jun-2020 000000000
US-20230146268-A1 Pharmaceutical composition or health functional food for prevention and treatment of obesity containing powder of novel hybrid mushroom as active ingredient Pending 29-Jun-2020 000000000
EP-4159225-A1 Novel pharmaceutical composition for treating dry eye syndrome Pending 25-May-2020 000000000 0
US-20230226137-A1 Novel pharmaceutical composition for treating dry eye syndrome Pending 25-May-2020 000000000
US-20200405802-A1 Novel multi-functional peptides and use thereof Active 19-Mar-2019 A61K38/10
To view NovaCell Technology’s complete patent history, request access »

NovaCell Technology Executive Team (5)

Name Title Board Seat Contact Info
Taehoon Lee Ph.D Owner, Chief Executive Officer & President
Seonho Ki Ph.D Chief Technology Officer
Kyunghee Jang CDO & Development Director
Mansoon Hwang Director
You’re viewing 4 of 5 executive team members. Get the full list »

NovaCell Technology Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AION Partners (New York) Real Estate Minority 000 0000 000000 0
Huons Global Corporation Minority 000 0000 000000 0
Korea Investment Partners Venture Capital Minority 000 0000 000000 0
Quantum Ventures Korea Venture Capital Minority 000 0000 000000 0
To view NovaCell Technology’s complete investors history, request access »

NovaCell Technology FAQs

  • When was NovaCell Technology founded?

    NovaCell Technology was founded in 2000.

  • Who is the founder of NovaCell Technology?

    Taehoon Lee Ph.D is the founder of NovaCell Technology.

  • Who is the CEO of NovaCell Technology?

    Taehoon Lee Ph.D is the CEO of NovaCell Technology.

  • Where is NovaCell Technology headquartered?

    NovaCell Technology is headquartered in Pohang-si, South Korea.

  • What industry is NovaCell Technology in?

    NovaCell Technology’s primary industry is Biotechnology.

  • Is NovaCell Technology a private or public company?

    NovaCell Technology is a Private company.

  • What is NovaCell Technology’s current revenue?

    The current revenue for NovaCell Technology is 000000.

  • How much funding has NovaCell Technology raised over time?

    NovaCell Technology has raised $11.7M.

  • Who are NovaCell Technology’s investors?

    AION Partners (New York), Huons Global, Korea Investment Partners, and Quantum Ventures Korea have invested in NovaCell Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »